Min Jo Kim Selected Research

MHY3200

5/2021	PPARα Agonist, MHY3200, Alleviates Renal Inflammation during Aging via Regulating ROS/Akt/FoxO1 Signaling.
8/2018	Hepatoprotective Effects of MHY3200 on High-Fat, Diet-Induced, Non-Alcoholic Fatty Liver Disease in Rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Min Jo Kim Research Topics

Disease

9	Pancreatic Neoplasms (Pancreatic Cancer) 04/2022 - 10/2020
6	Neoplasms (Cancer) 09/2021 - 04/2015
4	Starvation 09/2021 - 10/2016
4	Inflammation (Inflammations) 05/2021 - 10/2017
4	Body Weight (Weight, Body) 05/2021 - 01/2018
4	Insulin Resistance 08/2018 - 03/2016
2	Obesity 08/2018 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 01/2018 - 03/2016
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2021
1	Memory Disorders (Memory Loss) 06/2019
1	Alzheimer Disease (Alzheimer's Disease) 06/2019
1	Acute Kidney Injury (Acute Renal Failure) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Non-alcoholic Fatty Liver Disease 08/2018
1	Weight Gain 08/2018
1	Fatty Liver 01/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018
1	Muscular Atrophy (Muscle Atrophy) 09/2015
1	Sarcopenia 09/2015
1	Melanoma (Melanoma, Malignant) 04/2015
1	Pigmentation Disorders (Ito Syndrome) 04/2015

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 01/2022 - 01/2020
5	PhytochemicalsIBA 11/2021 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2018
2	Antineoplastic Agents (Antineoplastics)IBA 09/2021 - 10/2020
2	MHY3200IBA 05/2021 - 08/2018
2	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 01/2019
2	InflammasomesIBA 08/2018 - 10/2016
2	Insulin (Novolin)FDA Link 08/2018 - 01/2018
2	LipidsIBA 08/2018 - 01/2018
1	arctigeninIBA 04/2022
1	pregna-4,17-diene-3,16-dione (guggulsterone)IBA 01/2022
1	AcidsIBA 11/2021
1	SesquiterpenesIBA 11/2021
1	AlkaloidsIBA 09/2021
1	BenzylisoquinolinesIBA 09/2021
1	Guanosine Diphosphate (GDP)IBA 09/2021
1	CyclohexaneIBA 06/2021
1	Plant ExtractsIBA 01/2021
1	XanthonesIBA 01/2021
1	IsoflavonesIBA 01/2021
1	BenzophenonesIBA 01/2021
1	Ethanol (Ethyl Alcohol)IBA 01/2021
1	LactonesIBA 10/2020
1	glucose-regulated proteinsIBA 10/2020
1	Endoplasmic Reticulum Chaperone BiPIBA 10/2020
1	TriterpenesIBA 10/2020
1	Scopolamine (Hyoscine)FDA Link 06/2019
1	Cholinergic Agents (Cholinergics)IBA 06/2019
1	Mitogen-Activated Protein KinasesIBA 01/2019
1	Serotonin (5 Hydroxytryptamine)IBA 01/2019
1	N-feruloylserotoninIBA 01/2019
1	N-(p-coumaroyl)serotoninIBA 01/2019
1	Caspase 3 (Caspase-3)IBA 01/2019
1	CreatinineIBA 01/2019
1	Therapeutic UsesIBA 01/2019
1	lithospermate BIBA 08/2018
1	PhosphoenolpyruvateIBA 08/2018
1	difluoroacetic acid (difluoroacetate)IBA 08/2018
1	NAD (NADH)IBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	ResveratrolIBA 01/2018
1	Sirtuin 1IBA 01/2018
1	SRT1720IBA 01/2018
1	NF-kappa B (NF-kB)IBA 10/2017
1	barbituric acid (barbiturate)IBA 10/2017
1	AntioxidantsIBA 10/2017
1	Caspase 1 (ICE Protease)IBA 10/2016
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2016
1	propionic acid (potassium propionate)IBA 03/2016
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2015
1	Muscle Proteins (Muscle Protein)IBA 09/2015
1	Transcription Factors (Transcription Factor)IBA 09/2015
1	Ursolic AcidIBA 09/2015
1	Melanins (Melanin)IBA 04/2015
1	cryptotanshinoneIBA 04/2015
1	SolventsIBA 04/2015
1	Melanocyte-Stimulating Hormones (MSH)IBA 04/2015
1	Monophenol Monooxygenase (Tyrosinase)IBA 04/2015

Therapy/Procedure

2	Intraperitoneal Injections 01/2019 - 09/2015